|
| |
|
"The biggest changes of all will be in the arena of
medicine. It's so astonishingly primitive today, it really is ripe for change."
-- Paul Saffo, Director, Institute for the Future, predicting how the world will be
different 100 years from now (San Jose Mercury News, March 12, 1999, page
a4).
The field of IPT applications is
so huge and diverse that we can only outline here some major directions for IPT
research. As IPT information proliferates, and as interest in IPT grows,
the brightest minds in many fields will see new IPT-related problems to
investigate in their own domains. It will be a very exciting time.
The best way to ensure that this
research will get done is to let people know about IPT and IPTQ.com. The easiest
way is to send them an email.
Major directions for IPT research:
Documenting IPT as it was and is
Laboratory research
Medical literature research
Clinical research
Social, economic, and political
research
A few research ideas
 | Documenting IPT as it was and is.
The importance of this cannot be overemphasized. In more
than 120 man-years of clinical experience, the IPT doctors have tried a lot
of things and have observed a lot of things. Even among the four
long-term practitioners (only one still living), there have been differences and evolutions of
models and assumptions. If we start by focusing on just one set of
models and assumptions, we will miss out on the others. For example,
there seems to be a trend towards simplifying the procedure to make it more
like standard medical practice, in which only one drug or a few drugs are
given for a disease, along with the insulin. We might lose a lot if we
ignore the successes of the early practitioners in detoxifying the body and
improving general health, by using complex and comprehensive cocktails of
medications, only a few of which might be ordinarily indicated for the presenting illness.
Donato Perez Garcia MD 1 (1896-1971), the discoverer of IPT, left behind written
records of his work. Much of it is available now on IPTQ.com,
but much also waits for scanning and translation.
Donato Perez Garcia y
Bellon MD 2 (1930-2000), was born
into the world of IPT, practiced IPT for 44 years, and worked
side-by-side with his father for 16 years. He was our
living link to the origins of IPT, before any assumptions were
made. Including his father's experience, Dr. Perez Garcia y Bellon 2
represented
87 years of clinical experience with IPT, more than 60 percent of
all the experience to date. He and his father applied IPT to
more different diseases than anyone else ever has. Like the
last surviving healer from an ancient tribe in the Amazon, Dr. Perez Garcia y Bellon 2
was a living encyclopedia, a world treasure, an irreplaceable
resource. Now, due to his recent death, on November 23, 2000,
we have missed our chance to debrief him about his life's
mission. We need to preserve and study his papers. Much
of his work is available now on IPTQ.com, and much more needs to be
scanned and translated. His patient records, if they can be
saved, will provide a valuable resource for medical researchers who
want to know how he and his father treated diseases other than
cancer and arthritis.
Donato Perez Garcia
MD 3, is very energetic,
and is ready
to teach IPT as he practices it, and to participate in IPT research
programs, especially in Europe and the United States. With 17 years of
experience, including five years working directly with his father, he knows
more about IPT practice than anyone now living.
The papers of Jean-Claude
Paquette MD
do still exist, thanks to the kind intervention of his son Louis Paquette.
His notes and his
patient files could provide some very valuable insights into whatever IPT
innovations he made. And it would be wonderful to know exactly which
medications he used for the spectacular cases he presents in his book, Medicine
of Hope, published on IPTQ.com in English translation by
Aimé Ricci.
|
| Laboratory research. Much work
needs to be done to clarify the mechanisms of IPT action. We
have a lot of ideas, and a lot of pieces of this biomedical puzzle.
But the vast majority of these pieces were gathered by people who did not
know about IPT. Knowing about IPT will help researchers ask more
pertinent questions and try more IPT-relevant experiments. This could be a
big field. It is not hard to foresee big scientific conferences on IPT.
It is important to stress
the importance of doing much IPT research in animals (even though we are very
sensitive to the concerns of many people about the ethics of
this). Insulin clearly does a lot of things in the mammalian
body, and many of these things take place on the level of the whole
organism. Cell and tissue models, in vitro, are of great
value, but they cannot substitute for work with living animals.
|
| Medical literature
research. Just
give me a couple of biomedical research associates or graduate students
and we can do wonders just by searching through Medline. A few brief
forays into the medical literature there have convinced me that much of the
laboratory research we need has already been done, that it just needs to be
examined and reinterpreted in light of the experiences of IPT doctors.
Also scanning the literature will provide insights about how the IPT
protocol and its medication combinations can be improved. And it is
very likely to suggest new applications for IPT. This could lead to
publication of a lot of papers.
|
| Clinical research. Since IPT is
apparently so safe and benign, there seems to be little keeping doctors from
practicing it right now. Little except not knowing about it.
Some research doctors will want to test IPT in controlled clinical
trials. And other doctors will want to just jump in and start
treating patients in their private or institutional practices. Funding
mechanisms are already in place. Institutions are already in
place. Mechanisms are already in place for gathering results and
information from both pathways. As IPT catches on, we can foresee a
biomedical scientific society forming around it, and probably at least one
journal. And as IPT is applied to one disease after another, articles
will appear in many different specialized publications.
|
| Social, economic, and
political research.
Since IPT could represent a significant evolution in medical treatment,
with social, economic, and political repercussions, it is a great subject
for social science research. What will happen as IPT is
introduced? What can be done to aid its implementation? What
ethical issues are brought up by its introduction, and by its
widespread ignorance for the past 70 years?
|
Here are a few IPT research ideas:
Find the optimum timing for IPT -- administration of drugs, insulin, and
glucose.
Explore the effects of different doses of the ingredients. What
are the optimum levels?
What determines if a drug is better suited for IPT use?
Are there better mechanical ways to deliver the therapy? Perhaps
adaptations for emergency field use, for use in developing countries, for
veterinary use?
Gene chips to study expression of genes in different tissues during
IPT, to better understand the mechanisms involved.
Gene chip or other assay to determine a patient's susceptibility to IPT, and
perhaps to determine doses and timing.
New drugs that are optimized to work with IPT.
Old drugs that were too toxic, that can be revived to work with IPT.
Can IPT mechanisms be traced back to pre-mammalian life forms such as
nematodes? Can we improve IPT based on this knowledge?
Can IPT help prevent spinal cord damage after spinal injuries, and can it
help recover function after paralysis?
Does IPT stimulate proliferation and differentiation of stem cells, leading
to healing and regeneration?
Can IPT counteract the effects of antibiotic resistance of bacteria,
viruses, and parasites?
Can IPT counter drug resistance of malaria parasites by increasing
absorption of drugs into cells?
Does IPT improve treatment of gum infections?
Can IPT improve the survival rate of heart patients?
Can new medical devices be developed that assist and automate the IPT
process? Perhaps timed IV pumps that sense blood sugar and inject all
the components at the proper time.
What is the scientific explanation of the "Oncodiagnosticator"
developed by Drs. Perez Garcia 1 and 2, and can it be simplified, perfected, and
developed into a practical laboratory test?
This list could (and will) go on, and on, and on...
|
|
